Loading
Latest filing published 16 Nov 2021 for Maxcyte, INC., €751. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Ron Holtz is known so far (16 November 2021): an option exercise, €751, in Maxcyte, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.